[HTML][HTML] Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

BA Rahimi, A Thakkinstian, NJ White, C Sirivichayakul… - Malaria journal, 2014 - Springer
Abstract Background Malaria caused by Plasmodium vivax was long considered to have a
low mortality, but recent reports from some geographical areas suggest that severe and …

[HTML][HTML] Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic …

A Arya, LPK Foko, S Chaudhry, A Sharma… - International Journal for …, 2021 - Elsevier
Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria
therapy in endemic countries worldwide. This systematic review aims at presenting the …

[HTML][HTML] The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and …

RJ Commons, JA Simpson, K Thriemer… - The Lancet Infectious …, 2018 - thelancet.com
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …

[HTML][HTML] Epidemiology of Plasmodium vivax malaria in India

AR Anvikar, N Shah, AC Dhariwal… - The American journal …, 2016 - ncbi.nlm.nih.gov
Historically, malaria in India was predominantly caused by Plasmodium vivax, accounting for
53% of the estimated cases. After the spread of drug-resistant Plasmodium falciparum in the …

Surveillance of artemisinin resistance in Plasmodium falciparum in India using the kelch13 molecular marker

N Mishra, SK Prajapati, K Kaitholia… - Antimicrobial agents …, 2015 - Am Soc Microbiol
ABSTRACT Malaria treatment in Southeast Asia is threatened with the emergence of
artemisinin-resistant Plasmodium falciparum. Genome association studies have strongly …

[HTML][HTML] Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

N Mishra, K Kaitholia, B Srivastava, NK Shah… - Malaria journal, 2014 - Springer
Background Anti-malarial drug resistance in Plasmodium falciparum in India has historically
travelled from northeast India along the Myanmar border. The treatment policy for P …

[HTML][HTML] Malaria in North-East India: importance and implications in the era of elimination

DK Sarma, PK Mohapatra, DR Bhattacharyya… - Microorganisms, 2019 - mdpi.com
Worldwide and in India, malaria elimination efforts are being ramped up to eradicate the
disease by 2030. Malaria elimination efforts in North-East (NE) India will have a great …

[HTML][HTML] Antimalarial drug policy in India: past, present & future

AR Anvikar, U Arora, GS Sonal, N Mishra… - Indian Journal of …, 2014 - journals.lww.com
The use of antimalarial drugs in India has evolved since the introduction of quinine in the 17
th century. Since the formal establishment of a malaria control programme in 1953, shortly …

[HTML][HTML] Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study

HY Ehrlich, J Jones, S Parikh - The Lancet Microbe, 2020 - thelancet.com
Background Molecular markers for antimalarial drug resistance can be used to rapidly
monitor the emergence and spatial distribution of resistance to artemisinin-based …

[HTML][HTML] Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated …

N Valecha, D Savargaonkar, B Srivastava, BHK Rao… - Malaria journal, 2016 - Springer
Background Chloroquine has been the treatment of choice for acute vivax malaria for more
than 60 years. Malaria caused by Plasmodium vivax has recently shown resistance to …